Besides the potential to reduce the need for multiple PET scans, drastically reducing radiation exposure (reduced by a factor of (3) and increasing cost-effectiveness for both patient and healthcare system, this research could provide valuable insights into the interactions between amyloid, tau, and neurodegeneration and may help to understand the pathophysiology of AD and other dementia syndromes. This evidence concerns the gene MAPT and Alzheimer disease.